RE:RE:RE:RE:earningsI will try and find the link. Bruce said, 300,000 orders were sent out prior to October 17th. Then another 300,000 after October 17th were being ready to send out then approximately 700,000 orders were going to be shipped shortly after. I got the $70 per order as the average price per order which was provided by one of the provincial online distributor.
investor1964 wrote: Hey Peyton how do you know the number was 300,000 prior to Sept 30th? thx
Peyton wrote: Revs will be approximately $45 million. They sent out 300,000 ordered prior to Sept 31st at approx $70 per order. That's 21 million plus approx 28 million from med. That's around 49 million total. I'm hoping for somewhere around there but wouldnt be surprised too see 40 million if those orders weren't captured from before Sept 31st. If they havent then next quarter will be massive.
Meno111 wrote: I'm telling yea its going to be a net income. Not because of operations but because of non-operating income.
EPS .50+ and that's not including rev from biological assets. If you want a clear visualization of what happened in the quarter. The cash flow statement is the way. It removes all the clutter that occured from unrealized gains/losses, non-cash items etc.
Also.....
july-sept
Rev: $52.50m
COGS: ($24.28m)
Operating: ($60.96m) removed non-cash items and added 15% from june 30 amount
Working Capital: ($125m), a/r,ba,inv,prepaid budget
Total= ($157.74m)
oct-dec
Rev: $125m
COGS: ($77.62m)
Operating: ($70.11m) removed non-cash items and added 15%
Working Capital: ($125m)
Total: ($117.48m)
Operating: $275.22m
Investing: $300m
Financing: $600m
Assets: 6176.78m
Liabilities: (310m)
s/o: 350m
$5866.78m/350m= 16.76 book value
@5x = $83.81
The figures by the year end will not be the same as the ones stated above. However, as long as the book value and share price is above 16.76 and $83.81 respectively, I would be satisfied with the result.
Although, the question of whether it was because of fundamentals or other factors will be up for debate.